Nachrichten zur Vertex Pharmaceuticals Aktie

Is Vertex Pharmaceuticals Stock a Buy?

This high-flying biotech is trading on the cheap....…

Vertex (VRTX) Symkevi/Kalydeco Label Expansion Gets EU Nod

Vertex (VRTX) gets European approval for label expansion of Symkevi and Kalydeco combination pill in cystic fibrosis patients aged six…

Vertex Pharmaceuticals Board approves $500M stock buyback program

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

VERTEX PHARMACEUTICALS INC / MA: 8-K Report

8-K...…

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Jefferies London Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Here are the stocks seeing the most insider buying this week

CNBC's Brian Sullivan highlights the stocks seeing the most insider buying this week, on Worldwide Exchange, including names like Hanes…

Insiderhandel: EVP, Chief Adm, Leg & BD Off verkauft Aktien von Vertex Pharmaceuticals im Wert von 507.329 $

Parini, Michael - Vorstand - Tag der Transaktion: 2020-11-04...…

BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch

Todays Daily Dose brings you news about FDAs briefing information related to Biogens Alzheimers drug candidate ahead of the panel…

CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition

ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Nov. 04, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) and…

3 Reasons to Buy Vertex Pharmaceuticals and 1 Reason Not To

What will the drugmaker do once it has the cystic fibrosis market cornered?...…

VERTEX PHARMACEUTICALS INC / MA: 10-Q Report

10-Q...…

Vertex Pharmaceuticals Incorporated 2020 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex (VRTX) Beats on Q3 Earnings & Sales, Ups Sales View

Vertex (VRTX) beats estimates for both earnings and sales and raises revenue guidance for 2020....…

Vertex Pharmaceuticals Inc (VRTX) Q3 2020 Earnings Call Transcript

VRTX earnings call for the period ending September 30, 2020....…

Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Recap: Vertex Pharmaceuticals Q3 Earnings

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) decreased 1.4% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased…

Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals

These two rare-disease drug developers are experts at penetrating their markets....…

Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates

The biotech sector was in focus as Biogens (BIIB) Q3 results disappoint, Vertex (VRTX) stops study and Regenerons (REGN) Ebola…

Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity

Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity...…

Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co

Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co...…

Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?

Is (VRTX) Outperforming Other Medical Stocks This Year?...…

Pick These 5 Stocks With Superb Interest Coverage Ratio

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as…

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $220.51 in the latest trading session, marking a +1.11% move from the prior day....…

Excellent Entry Point For Vertex Pharmaceuticals After Giving Away -20%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharmaceuticals: Kurseinbruch übertrieben? Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Thomas Bergmann, Redakteur beim Anlegermagazin "Der Aktionär", nimmt die Aktie des US-Biotechkonzerns Vertex…

Why Arrowhead Pharmaceuticals Is Trading Higher Today

Arrowhead Pharmaceuticals (NASDAQ: ARWR) shares are trading higher on Thursday on news that Vertex Pharmaceuticals discontinued its trial of a…

Vertex (VRTX) is an Incredible Growth Stock: 3 Reasons Why

Vertex (VRTX) could produce exceptional returns because of its solid growth attributes....…

Organogenesis Holdings, Anavex Life Sciences leads healthcare gainers; Vertex Pharmaceuticals, Aphria among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Vertex Pharmaceuticals Stock Is Slumping Today

Investors are concerned about Vertexs pipeline after a rare miss in the clinic....…

FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade

Todays Daily Dose brings you news about AnaptysBios generalized pustular psoriasis trial results, Cyclerion discontinuing its Sickle Cell Disease drug…

Vertex stock falls after protein-deficiency drug development stopped

Vertex Pharmaceuticals Inc. VRTX stock fell in the extended session Wednesday after the biotech company said it would stop developing…

Vertex Pharma -7.9% as it drops VX-814 study, development (updated)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharma -7.9% as it drop VX-814 study, development

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?

Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $276.09, marking a +0.54% move from the previous day....…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $265.82, marking a +1.85% move from the previous day....…

Where Will Vertex Pharmaceuticals Be in 5 Years?

The biotech company is up more than 23% in 2020, but where will it be in five years?...…

Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?

Is (VRTX) Outperforming Other Medical Stocks This Year?...…

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $270.31, moving +0.96% from the previous trading session....…

Vertex präsentiert auf virtuellen Mukoviszidose-Konferenzen in Europa und Nordamerika neue Daten zum Langzeiteinsatz von CFTR-Modulatoren

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) kündigte heute an, dass Daten aus dem Unternehmensportfolio von Medikamenten gegen Mukoviszidose (Cystic Fibrosis,…